great opportunity here ...
Outlook:
Licensing - secure significant new deal
Evamist™ - VIVUS files Evamist marketing application with FDA
(achieved September 2006)
Testosterone MDTS® - VIVUS starts Phase 3 trials (H1 2007)
Contraceptive sprays - start proof of concept trials of combinations
Testosterone MD-Lotion® - complete Phase 2 trials (H1 2007)
New products - one successful proof of concept trial
Fentanyl UDTS™ - open IND with FDA for Phase 2
Cash - maintain above $10 million at all times
ACR
acrux limited
Add to My Watchlist
6.25%
!
1.7¢

looking good
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.001(6.25%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.6¢ | 1.7¢ | 1.6¢ | $6.279K | 376.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 741559 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 193057 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 741559 | 0.016 |
6 | 1259314 | 0.015 |
3 | 420000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 193057 | 2 |
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
0.021 | 203466 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online